Aug 21, 2026 08:00AM

Aug 21, 2026 08:00AM

Dec 19, 2025 06:24AM

Dec 18, 2025 08:04AM

Dec 18, 2025 08:00AM

Nov 4, 2025 07:00AM

Oct 8, 2025 08:03AM Werewolf Therapeutics gets FDA fast track status for cancer therapy

Oct 8, 2025 08:00AM

Aug 14, 2025 07:00AM

May 8, 2025 07:00AM

Apr 21, 2025 04:29AM

Mar 11, 2025 07:00AM

Mar 23, 2023 07:00AM

Nov 10, 2022 09:00AM Werewolf Therapeutics Presents Preclinical Data on mWTX-330, a Surrogate IL-12 INDUKINE™ Molecule, at the Society for Immunotherapy of Cancer Annual Meeting

Nov 10, 2022 07:00AM

Aug 11, 2022 07:00AM

May 10, 2022 07:00AM

Apr 7, 2022 07:01AM

Apr 7, 2022 07:00AM

Aug 18, 2021 07:37AM

Aug 18, 2021 07:30AM Werewolf Therapeutics Announces Clinical Trial Collaboration with Merck on its WTX-124 INDUKINE™ Program

329,602 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All